Page last updated: 2024-10-31

metoprolol and Purpura, Thrombotic Thrombocytopenic

metoprolol has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Heavner, MS1
Cucci, MD1
Barlow, B1
Bell, CM1
Eng, CC1
Erdman, G1
Li, M1
Smith, SE1
Aldhaeefi, M1
Thompson Bastin, ML1
Hawkins, WA1
Rose, C1
Lankford, A1

Reviews

1 review available for metoprolol and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Caring for two in the ICU: Pharmacologic management of pregnancy-related complications.
    Pharmacotherapy, 2023, Volume: 43, Issue:7

    Topics: Female; Humans; Intensive Care Units; Metoprolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications,

2023